Posted on

Date of submission of the HTAC Recommendation: 01 December 2025
Date of notification to HTAC on the SOH decision: 29 April 2026

The Secretary of Health (SOH) concurs with the final recommendation of the HTA Council on moderate complexity nucleic acid amplification tests  (NAATs) for the diagnosis of  multi-drug resistant tuberculosis (MDR-TB) with isoniazid (INH) and rifampicin (RIF) resistance testing through Department of Health (DOH) Department Circular No. 2026 – 0181 “Cascading of Recommendation for Government Financing on Moderate Complexity Nucleic Acid Amplification Tests  (NAATs) for the Diagnosis of  Multi-drug Resistant Tuberculosis (MDR-TB) with Isoniazid (INH) and Rifampicin (RIF) Resistance testing” published on 28 April 2026.  

As a final recommendation, the HTA Council recommends moderate complexity NAATs for the diagnosis of MDR-TB with INH and RIF resistance testing, for financing of DOH and/or PhilHealth.

For further details, please refer to the documents below:

[Public Copy] HTA Council Final Recommendation Moderate Complexity NAATs (01 December 2025)Download
[DOH DC 2026-0181] SOH Decision on HTAC Final Recommenation for Moderate Complexity NAATsDownload